Acute Coronary Syndrome: Treatment Strategies and Outcomes in Patients Admitted to a Tertiary Care Hospital in Palestine
Abdallah Damin Abukhalil,Shahd Hamad,Zain Swaileh,Aseel Ghanem,Sarah Abumadi,Raed Madia,Ni'meh Al-Shami
DOI: https://doi.org/10.2147/ppa.s467924
2024-06-13
Patient Preference and Adherence
Abstract:Abdallah Damin Abukhalil, Shahd Hamad, &ast Zain Khalid Swaileh, &ast Aseel Wasel Ghanem, &ast Sarah Abumadi, &ast Raed Madia, Ni'meh Own Al-Shami Pharmacy Department, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit, West Bank, Palestine &astThese authors contributed equally to this work Correspondence: Abdallah Damin Abukhalil; Raed Madia, Pharmacy Department, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit, West Bank, Palestine, Email ; Background: Acute coronary syndrome (ACS) is the leading cause of death worldwide despite advances in treatment and prevention measures. This study aimed to explore ACS treatment strategies (ischemia-guided vs early invasive) and risk factors among patients diagnosed with ACS in a tertiary care hospital in Palestine and to evaluate related outcomes regarding future events and standard clinical guidelines. Methods: This retrospective cohort study reviewed patient data from a Palestinian medical hospital. The study included 255 patients ≥ 18 years who were hospitalized between January 2021 and December 2021 and diagnosed with ACS. The data were analyzed using the Statistical Package for Social Science (SPSS). Results: 71% of the participants were males. The mean age was 59.59± 11.56 years. Smoking, diabetes, and hypertension were the most common risk factors. Unstable angina (UA) was the most prevalent ACS type, accounting for 43.1% (110) of cases, whereas NSTEMI accounted for 39.2% (100) and STEMI accounted for 17.6% (45) of cases. An ischemic-guided strategy approach was used in 71% (181) of the patients. Upon discharge, the most prescribed medication classes were antiplatelets (97.6%), statins (87.1%), PPIs (72.5%), and antihypertensives (71.8%). Treatment strategies were selected according to the clinical guidelines for most ACS types. Conclusion: ACS management in Palestine continues to evolve to overcome barriers, decrease patient mortality, and decrease hospital stay. UA and NSTEMI were the most common ACS diagnoses at admission, and the ischemic strategy was the most common modality. The findings of this study call for an increased awareness of CVD risk factors, resource availability, and adherence to clinical guidelines to improve patient outcomes and community health. Keywords: acute coronary syndrome, ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, unstable angina, ischemia-guided strategy, early invasive strategy Acute coronary syndrome (ACS) refers to a group of disorders that includes ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). ACS is characterized by episodes of chest pain, often with dynamic ECG changes due to a dramatic reduction in the blood supply to the myocardium. 1 This is caused by atherosclerosis, leading to partial or near-complete coronary artery occlusion, causing ischemia to the myocardium and potentially infarction. 2 Risk factors for ACS include age, family history, obesity, hypertension, hyperlipidemia, diabetes mellitus, male sex, smoking, unhealthy diet, and physical inactivity. 3 Despite significant advancements in the diagnosis and management of ACS, it remains the primary cause of mortality worldwide. 4 For example, ACS accounts for one-third of the total deaths among people aged > 35 years old. 3 According to statistics from the American Heart Association (AHA), from 2005 to 2014, the estimated yearly incidence of myocardial infarction was 605,000 new and 200,000 recurrent attacks. It is expected that 170,000 of these 805,000 first and recurring incidents will be silent. 5 In Palestine, ACS accounted for 20% of all reported fatalities in the age range 20–59 years in 2012. 6 The medical management of ACS depends on the patient presentation, clinical assessment, cardiac biomarkers, type of ACS, and availability of primary percutaneous coronary intervention (PCI) hospitals. Primary PCI and optimal medical management can improve patient outcomes after MI. 7 The American Heart Association (AHA) recommends emergent catheterization and percutaneous intervention (PCI) with a door-to-procedure time of less than 90 minutes for STEMI patients with fibrinolysis reserved for individuals who do not have access to early primary PCI. 8 Traditional treatment for NSTEMI/UA involves an ischemia-guided strategy, which includes initial rapid treatment with aspirin and heparin followed by non-invasive testing for further risk stratification to determine the necessity of urgent catheterization or revascularization. 3 However, an early inva -Abstract Truncated-
medicine, general & internal